missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ VHLL Polyclonal Antibody
Rabbit Polyclonal Antibody
Marke: Invitrogen™ PA571282
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
This target displays homology in the following species: Human: 100%.
Von Hippel-Lindau (VHL) tumor suppressor protein is a component of an E3 ubiquitin ligase complex that selectively ubiquitinates the alpha subunit of the hypoxia-inducible factor (HIF) transcription factor for proteasome-mediated degradation. Inactivation of VHL causes VHL disease and sporadic kidney cancer. This gene encodes a VHL homolog that lacks one of two key domains necessary for VHL function. This gene may contribute to the regulation of oxygen homeostasis and neovascularization during placenta development. This gene is intronless, and can also be interpreted as a retrotransposed pseudogene of the VHL locus located on chromosome 3. The same publication also indicates that this protein binds HIF alpha but fails to recruit the E3 ubiquitin ligase complex, and it therefore functions as a dominant-negative VHL protein and a protector of HIF alpha.
Spezifikation
| VHLL | |
| Polyclonal | |
| Unconjugated | |
| VHLL | |
| VHL pseudogene; VHLL; VHL-like protein; VHLP; VLP; von Hippel-Lindau tumor suppressor like; von Hippel-Lindau tumor suppressor-like; von Hippel-Lindau-like protein | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 391104 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Liquid |
| Western Blot | |
| 0.5 mg/mL | |
| PBS with 2% sucrose and 0.09% sodium azide | |
| Q6RSH7 | |
| VHLL | |
| synthetic peptide directed towards the N-terminal region of human VHLL. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur